<?xml version="1.0" encoding="utf-8"?>
<journal>
<title>Medical Laboratory Journal</title>
<title_fa>Medical Laboratory Journal</title_fa>
<short_title>mljgoums</short_title>
<subject>Medical Sciences</subject>
<web_url>http://mlj.goums.ac.ir</web_url>
<journal_hbi_system_id>1</journal_hbi_system_id>
<journal_hbi_system_user>admin</journal_hbi_system_user>
<journal_id_issn>2538-4449</journal_id_issn>
<journal_id_issn_online>2538-4449</journal_id_issn_online>
<journal_id_pii></journal_id_pii>
<journal_id_doi>10.61186/mlj</journal_id_doi>
<journal_id_iranmedex></journal_id_iranmedex>
<journal_id_magiran></journal_id_magiran>
<journal_id_sid></journal_id_sid>
<journal_id_nlai></journal_id_nlai>
<journal_id_science></journal_id_science>
<language>en</language>
<pubdate>
	<type>jalali</type>
	<year>1404</year>
	<month>10</month>
	<day>1</day>
</pubdate>
<pubdate>
	<type>gregorian</type>
	<year>2026</year>
	<month>1</month>
	<day>1</day>
</pubdate>
<volume>20</volume>
<number>1</number>
<publish_type>online</publish_type>
<publish_edition>1</publish_edition>
<article_type>fulltext</article_type>
<articleset>
	<article>


	<language>en</language>
	<article_id_doi></article_id_doi>
	<title_fa></title_fa>
	<title>Effect of Urtica dioica agglutinin (a plant lectin) on breast cancer cell growth   in MCF-7 cells</title>
	<subject_fa>پزشکی مولکولی</subject_fa>
	<subject>Molecular Medicine</subject>
	<content_type_fa>Research Article</content_type_fa>
	<content_type>Research Article</content_type>
	<abstract_fa></abstract_fa>
	<abstract>&lt;span style=&quot;font-size:11pt&quot;&gt;&lt;span style=&quot;line-height:150%&quot;&gt;&lt;span calibri=&quot;&quot; style=&quot;font-family:&quot;&gt;&lt;b&gt;&lt;span style=&quot;font-size:12.0pt&quot;&gt;&lt;span style=&quot;line-height:150%&quot;&gt;&lt;span new=&quot;&quot; roman=&quot;&quot; style=&quot;font-family:&quot; times=&quot;&quot;&gt;Background&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/b&gt;&lt;span style=&quot;font-size:12.0pt&quot;&gt;&lt;span style=&quot;line-height:150%&quot;&gt;&lt;span new=&quot;&quot; roman=&quot;&quot; style=&quot;font-family:&quot; times=&quot;&quot;&gt;: The high global mortality of breast cancer in women necessitates novel therapies with fewer side effects.. Urtica dioica agglutinin (UDA), a lectin from stinging nettle, exhibits antiproliferative properties in various cancers, but its effect on breast cancer cells remain underexplored. This study evaluates UDA&amp;rsquo;s cytotoxic potential against Michigan Cancer Foundation-7 (&lt;i&gt;MCF-7&lt;/i&gt;) breast cancer cells while assessing its impact on &amp;nbsp;non-tumorigenic human mammary epithelial (&lt;i&gt;MCF-10A&lt;/i&gt;) and Human embryonic kidney (&lt;i&gt;HEK-293&lt;/i&gt;) cells.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;br&gt;
&lt;span style=&quot;font-size:11pt&quot;&gt;&lt;span style=&quot;line-height:150%&quot;&gt;&lt;span calibri=&quot;&quot; style=&quot;font-family:&quot;&gt;&lt;b&gt;&lt;span style=&quot;font-size:12.0pt&quot;&gt;&lt;span style=&quot;line-height:150%&quot;&gt;&lt;span new=&quot;&quot; roman=&quot;&quot; style=&quot;font-family:&quot; times=&quot;&quot;&gt;Methods&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/b&gt;&lt;span style=&quot;font-size:12.0pt&quot;&gt;&lt;span style=&quot;line-height:150%&quot;&gt;&lt;span new=&quot;&quot; roman=&quot;&quot; style=&quot;font-family:&quot; times=&quot;&quot;&gt;: UDA purification was performed via affinity chromatography from Urtica dioica rhizomes, confirmed by SDS-PAGE (8.5&amp;ndash;9.5 kDa) and agglutination assays. &lt;i&gt;MCF-7&lt;/i&gt;, &lt;i&gt;MCF-10A&lt;/i&gt;, and &lt;i&gt;HEK-293&lt;/i&gt; cells were treated with different concentrations of UDA (7.5&amp;ndash;480 &amp;micro;g/ml) for 24 and 48 hours. Cytotoxicity was assessed using MTT assays to measure cell viability.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;br&gt;
&lt;span style=&quot;font-size:11pt&quot;&gt;&lt;span style=&quot;line-height:150%&quot;&gt;&lt;span calibri=&quot;&quot; style=&quot;font-family:&quot;&gt;&lt;b&gt;&lt;span style=&quot;font-size:12.0pt&quot;&gt;&lt;span style=&quot;line-height:150%&quot;&gt;&lt;span new=&quot;&quot; roman=&quot;&quot; style=&quot;font-family:&quot; times=&quot;&quot;&gt;Results&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/b&gt;&lt;span style=&quot;font-size:12.0pt&quot;&gt;&lt;span style=&quot;line-height:150%&quot;&gt;&lt;span new=&quot;&quot; roman=&quot;&quot; style=&quot;font-family:&quot; times=&quot;&quot;&gt;: UDA significantly inhibited &lt;i&gt;MCF-7&lt;/i&gt; proliferation in a dose- and time-dependent manner (&lt;i&gt;P&lt;/i&gt; &lt; 0.01 at 24 hours; &lt;i&gt;P&lt;/i&gt; &lt; 0.0001 at 48 hours). At 240 &amp;micro;g/ml (during 48 hours), viability dropped below 50%, while normal &lt;i&gt;HEK-293&lt;/i&gt; cells showed &lt;30% toxicity. &lt;i&gt;MCF-10A&lt;/i&gt; proliferation remained unaffected, even at 480 &amp;micro;g/ml.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt; &lt;span style=&quot;font-size:12.0pt&quot;&gt;&lt;span style=&quot;line-height:150%&quot;&gt;&lt;span new=&quot;&quot; roman=&quot;&quot; style=&quot;font-family:&quot; times=&quot;&quot;&gt;IC&lt;sub&gt;50&lt;/sub&gt; was 389.7 207.0 &amp;mu;g/mL for 24 and 48 hours.&amp;nbsp; &lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;br&gt;
&lt;span style=&quot;font-size:11pt&quot;&gt;&lt;span style=&quot;line-height:150%&quot;&gt;&lt;span calibri=&quot;&quot; style=&quot;font-family:&quot;&gt;&lt;b&gt;&lt;span style=&quot;font-size:12.0pt&quot;&gt;&lt;span style=&quot;line-height:150%&quot;&gt;&lt;span new=&quot;&quot; roman=&quot;&quot; style=&quot;font-family:&quot; times=&quot;&quot;&gt;Conclusion&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/b&gt;&lt;span style=&quot;font-size:12.0pt&quot;&gt;&lt;span style=&quot;line-height:150%&quot;&gt;&lt;span new=&quot;&quot; roman=&quot;&quot; style=&quot;font-family:&quot; times=&quot;&quot;&gt;: UDA targets breast cancer cells (&lt;i&gt;MCF-7&lt;/i&gt;) with minimal toxicity to normal cells, positioning it as a promising anticancer candidate. Determining the mechanism of its action and apoptosis-inducing potential needs further research in the future. &amp;nbsp;.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;</abstract>
	<keyword_fa></keyword_fa>
	<keyword>UDA, Stinging nettle,  MCF-7 cell line, anticancer candidate, Cytotoxicity,</keyword>
	<start_page>0</start_page>
	<end_page>0</end_page>
	<web_url>http://mlj.goums.ac.ir/browse.php?a_code=A-10-1949-1&amp;slc_lang=en&amp;sid=1</web_url>


<author_list>
	<author>
	<first_name>Esmail</first_name>
	<middle_name></middle_name>
	<last_name>Samadian</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>essamadian@gmail.com</email>
	<code>100319475328460032160</code>
	<orcid>100319475328460032160</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Medical Laboratory research Center, Golestan University of Medical Sciences, Gorgan, Iran</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Arash</first_name>
	<middle_name></middle_name>
	<last_name>Golalipour</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>Arash3096@gmail.com</email>
	<code>100319475328460032161</code>
	<orcid>100319475328460032161</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>2Department of Pathobiology, School of Veterinary Medicine, Shiraz University, Shiraz, Iran</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Mohammadali</first_name>
	<middle_name></middle_name>
	<last_name>Vakili</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>vakili@goums.ac.ir</email>
	<code>100319475328460032162</code>
	<orcid>100319475328460032162</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>3Health Management and Social Development Research Center, Department of Biostatistics and Epidemiology, Faculty of Health, Golestan University of Medical Sciences, Gorgan, Iran</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Hasan</first_name>
	<middle_name></middle_name>
	<last_name>Mohammed</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>hassan.iqyousif@gmail.com</email>
	<code>100319475328460032163</code>
	<orcid>100319475328460032163</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>4Laboratories of Imam Al-Sadiq Hospital, Ministry of Health, Babylon Governorate, Iraq;  Medical Laboratory research Center, Golestan University of Medical Sciences, Gorgan, Iran</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>azam</first_name>
	<middle_name></middle_name>
	<last_name>rashidbaghan</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>rashidbaghan@yahoo.com</email>
	<code>100319475328460032164</code>
	<orcid>100319475328460032164</orcid>
	<coreauthor>Yes
</coreauthor>
	<affiliation>5Neonatal and Children’s Health Research Center, Golestan University of Medical Sciences, Gorgan, Iran</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


</author_list>


	</article>
</articleset>
</journal>
